<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1141">
  <stage>Registered</stage>
  <submitdate>25/02/2006</submitdate>
  <approvaldate>1/03/2006</approvaldate>
  <actrnumber>ACTRN12606000084583</actrnumber>
  <trial_identification>
    <studytitle>The neuro-behavioural effects of Dexmedetomidine Vs Morphine in adult patients after cardiac surgery</studytitle>
    <scientifictitle>The neuro-behavioural effects of Dexmedetomidine Vs Morphine in adult patients after cardiac surgery</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Delirium post cardiac surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will receive intravenous morphine 30-70 mic/kg/hr infusion, up to 48hrs.</interventions>
    <comparator>Patients will receive intravenous Dexmedetomidine 0.3-0.7 mic/kg/hr infusion, up to 48hrs.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Delirium Rate as assessed using the Intensive care Confusion Assessment Method (CAM-ICU.  Delirium will be stratified into hypo, hyper-active or severe agitation.</outcome>
      <timepoint>Days 1, 3 and 5.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>1. Lengths of ICU stay.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>2. Time to extubation in ICU.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>3. Lengths of hospital stay.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>4. In hospital mortality rate.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>5. Self-extubationin ICU.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>6. Intubation period beyond 12 hrs in ICU.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients undergoing cardiac surgery on bypass including CABG, valve surgery, combination CABG and/or valve replacement procedures.·Patients who have given consent.</inclusivecriteria>
    <inclusiveminage>60</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Allergy to any of the trial drugs.·Creatinine &gt;134 mmol/L or creatinine clearance calculated by Cockcroft Gault formula of &lt;50ml/min·Receiving other alpha 2 agonists like Clonidine.·Patients on psychotic drugs other than night time hypnotics.·Pre operative dementia/ Parkinsonism/ Other cerebral illness.·Non English speaking patients.·Weight greater than 150 Kgs.·Surgery involving intracranial vasculature within last 3 months·Surgery involving free flap within last 3 months ·Receiving neuromuscular blockers for reasons other than performing endotracheal intubation.·Patients receiving regional analgesia·Haemodynamic instability, i.e. HR &lt; 55 beats per minute, Systolic blood pressure &lt; 90 mmHg.·Failure to obtain consent.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>randomised sealed envelopes</concealment>
    <sequence>Random computer generation in blocks</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/08/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Prince of Wales Hospital</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Intensive care research fund</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Prince of Wales Hospital Ethics</ethicname>
      <ethicaddress />
      <ethicapprovaldate>20/05/2004</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Yahya Shehabi</name>
      <address>Intensive Care Unit
Prince of Wales Hospital
Level 1
Dickinson Building
Barker St
Randwick NSW 2031</address>
      <phone>+61 2 93824721</phone>
      <fax />
      <email>yshehabi@ozemail.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Naomi Hammond</name>
      <address>Intensive Care Unit
Prince of Wales Hospital
Level 1
Dickinson Building
Barker St
Randwick NSW 2031</address>
      <phone>+61 2 93824720</phone>
      <fax />
      <email>naomi.hammond@sesiahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>